ADIPOQ and colorectal carcinoma: ADIPOQ’s protective effects through a reduced TNF-α inflammatory response via ADIPOR1-dependent activation were previously evaluated in endothelial cells of the umbilical vein; however, this association has scarcely been explored in CRC [20].